Expands access to much-needed iron therapy for millions of US patients Builds Sandoz portfolio of high-quality injectable iron therapies and sets stage for future launches Strengthens US supply of ...
Panelists discuss how chronic kidney disease leads to iron deficiency anemia through a complex interplay of impaired iron absorption, increased hepcidin production driven by inflammatory cytokines, ...
First and only high-dose intravenous iron for iron deficiency anemia of various etiologies SHIRLEY, N.Y.--(BUSINESS WIRE)--American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved the first and only IV iron replacement therapy indicated for people with heart failure and iron ...
BASKING RIDGE, N.J. and SHIRLEY, N.Y., May 6, 2021 /PRNewswire/ -- Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug ...
FERAHEME (Ferumoxytol) 30mg/mL injection by AMAG Pharmaceuticals Feraheme (ferumoxytol injection), an intravenous iron replacement therapy, has been made available by AMAG Pharmaceuticals for the ...
Injectafer, made by Daiichi Sankyo, is a ferric carboxymaltose injection treatment for iron deficiency in adult patients with heart failure to improve exercise capacity, according to a June 5 company ...
I’ve been feeling constantly tired lately, and no matter how much I sleep, I don’t feel refreshed.” This is a common ...
Patna: State health minister Mangal Pandey on Thursday launched ferric carboxymaltose (FCM) therapy to address the problem of ...
FERAHEME (Ferumoxytol) 30mg/mL injection by AMAG Pharmaceuticals The FDA has approved Feraheme (ferumoxytol injection, from AMAG Pharmaceuticals) for the treatment of iron deficiency anemia in adults ...